PAFAH1B1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.282770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.556600E-01
Normal-vs-Stage2
3.994300E-02
Normal-vs-Stage3
1.845810E-02
Normal-vs-Stage4
2.807200E-01
Stage1-vs-Stage2
4.277400E-01
Stage1-vs-Stage3
1.415590E-01
Stage1-vs-Stage4
9.004400E-01
Stage2-vs-Stage3
2.287000E-01
Stage2-vs-Stage4
6.360000E-01
Stage3-vs-Stage4
2.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.358200E-01
Normal-vs-AfricanAmerican
3.455800E-01
Normal-vs-Asian
1.881660E-02
Caucasian-vs-AfricanAmerican
4.586600E-01
Caucasian-vs-Asian
1.319200E-01
AfricanAmerican-vs-Asian
7.057500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.170420E-01
Normal-vs-Female
1.573960E-01
Male-vs-Female
3.654200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.062400E-01
Normal-vs-Age(41-60Yrs)
3.279000E-01
Normal-vs-Age(61-80Yrs)
8.419600E-02
Normal-vs-Age(81-100Yrs)
3.386200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.723200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.050400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.488800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.064800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.932400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.284900E-03
Normal-vs-Daily Drinker
1.702310E-02
Normal-vs-Weekly Drinker
7.605700E-02
Normal-vs-Occasional Drinker
4.382600E-01
Normal-vs-Social Drinker
5.678400E-01
Non Drinker-vs-Daily Drinker
7.113000E-01
Non Drinker-vs-Weekly Drinker
2.737400E-01
Non Drinker-vs-Occasional Drinker
2.927900E-02
Non Drinker-vs-Social Drinker
5.713600E-02
Daily Drinker-vs-Weekly Drinker
4.738400E-01
Daily Drinker-vs-Occasional Drinker
4.594000E-02
Daily Drinker-vs-Social Drinker
8.981600E-02
Weekly Drinker-vs-Occasional Drinker
2.474600E-01
Weekly Drinker-vs-Social Drinker
2.480800E-01
Occasional Drinker-vs-Social Drinker
8.753800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.774800E-01
Normal-vs-Grade 2
9.071200E-01
Normal-vs-Grade 3
9.269000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.634300E-02
Grade 1-vs-Grade 3
4.182100E-02
Grade 1-vs-Grade 4
4.774800E-01
Grade 2-vs-Grade 3
6.924800E-01
Grade 2-vs-Grade 4
9.071200E-01
Grade 3-vs-Grade 4
9.269000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.849900E-02
Normal-vs-NonDiabetic
1.521370E-01
Diabetic-vs-NonDiabetic
2.661000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.177800E-03
Normal-vs-NoPancreatitis
1.428850E-01
Pancreatitis-vs-NoPancreatitis
1.312570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.421600E-01
Normal-vs-N1
4.704300E-02
N0-vs-N1
2.306400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.417690E-02
Normal-vs-TP53-NonMutant
4.942000E-01
TP53-Mutant-vs-TP53-NonMutant
1.993560E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
